IRVINE, Calif., Nov. 03, 2022 — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare, genetic, mitochondrial diseases, today announced that the company’s management team will participate at three upcoming healthcare conferences. Jefferies Global Healthcare Conference Date: November 15 – 17, 2022Location:… Continue reading Reneo Pharmaceuticals to Participate at Upcoming Investor Conferences